Melanoma of the Female Genital Tract

Gynecologic Cancer: Controversies in Management

Volumn , Issue , 2004, Pages 931-939

  Trimble, Edward L ^a,b   Kosary, Carol ^b   Mooney, Margaret ^b   Saxman, Scott ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646072282     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-07142-3.50072-5     Document Type: Chapter

References (41)

1. MA Weinstock (1994) Malignant melanoma of the vulva and vagina in the United States: Patterns of incidence and population-based estimated of survival. Am J Obstet Gynecol 171 1225-1230.
2. B Ragnarsson-Olding, H Johansson, L-E Rutqvist, et al. (1993) Malignant melanoma of the vulva and vagina: Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984. Cancer 71 1893-1897.
3. WT Creasman, JL Phillips and HR Menck (1999) A survey of hospital management practices for vulvar melanoma. J Am Coll Surg 188 670-675.
4. BK Ragnarsson-Olding, LR Kanter-Lewensohn, B Lagerlog, et al. (1999) Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: Clinical observations and histopathologic features. Cancer 86 1273-1284.
5. American Joint Committee on Cancer (2002) Melanoma of the skin. AJCC Cancer Staging Manual 6th ed. New York: Springer 209-217.
6. GL Phillips, BN Bundy, T Okagaki, et al. (1994) Malignant melanoma of the vulva treated by radical hemivulvectomy: A prospective study of the Gynecologic Oncology Group. Cancer 73 2626-2632.
7. KC Podratz, TA Gaffey, RE Symmonds, et al. (1983) Melanoma of the vulva: An update. Gynecol Oncol 16 153-168.
8. CM Balch, AC Buzaid, S-J Soong, et al. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19 3635-3648.
9. CM Balch, S-J Soong, JE Gershenwald, et al. (2001) Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 3622-3634.
10. WH Clark, L From, EA Bernadino, et al. (1969) The histogenesis and biologic behavior of primary human malignant melanoma of the skin. Cancer Res 29 705-726.
11. A Breslow (1970) Thickness, cross-sectional areas, and depth of invasion in the prognosis of cutaneous melanomas. Ann Surg 172 902-908.
12. AF Chung, JM Woodruff and JL Lewis (1975) Malignant melanoma of the vulva: A report of 44 cases. Obstet Gynecol 45 638-646.
13. U Beller, RI Demopoulos and EM Beckman (1986) Vulvovaginal melanoma: A clinicopathologic study. J Reprod Med 31 315-319.
14. GC Reid, RW Schmidt, JA Roberts, et al. (1989) Primary melanoma of the vagina: A clinicopathologic analysis. Obstet Gynecol 74 190-199.
15. ID Fleming, JS Cooper, DE Henson, et al. (1997) Malignant melanoma of the skin. AJCC Cancer Staging Manual 5th ed. Philadelphia: Lippincott-Raven 163-167.
16. CM Balch, SJ Soong, T Smith, et al. (2001) Long-term results of a prospective surgical trial comparing 2 cm versus 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 8 101-108.
17. UU Veronesi and N Cascinelli (1991) Narrow excision (1 cm margin): A safe procedure for thin cutaneous melanoma. Arch Surg 126 438-441.
18. M Scheistroen, C Trope, J Kaern, et al. (1995) Malignant melanoma of the vulvar FIGO stage I: Evaluation of prognostic markers in 75 patients with emphasis on DNA ploidy and surgical treatment. Cancer 75 72-80.
19. MG Bradgate, TP Rollason, CC McConkey, et al. (1990) Malignant melanoma of the vulva: A clinico-pathological study of 50 women. Br J Obstet Gynaecol 97 124-133.
20. EL Trimble, JL Lewis Jr, LL Williams, et al. (1992) Management of vulvar melanoma. Gynecol Oncol 45 254-258.
21. G Raber, V Mempel, C Jackisch, et al. (1996) Malignant melanoma of the vulva: Report of 89 patients. Cancer 78 2353-2358.
22. P DeMatos, D Tyler and HF Seigler (1998) Mucosal melanoma of the female genitalia: A clinicopathologic study of 43 cases at Duke University Medical Center. Surgery 124 38-48.
23. BK Ragnarsson-Olding, BR Nilsson, LR Kaner-Lewensohn, et al. (1999) Malignant melanoma of the vulvar in a nationwide, 25-year study of 219 Swedish females: Predictors of survival. Cancer 86 1285-1293.
24. PG Rose, MS Piver, Y Tsukada, et al. (1988) Conservative therapy for melanoma of the vulva. Am J Obstet Gynecol 159 520-525.
25. EWK Tasseron, EP van der Esch, AAM Hart, et al. (1992) A clinico-pathological study of 30 melanomas of the vulva. Gynecol Oncol 46 170-175.
26. WP Irwin, RL Legallo, MH Stoler, et al. (2001) Vulvar melanoma: A retrospective analysis and literature review. Gynecol Oncol 83 457-465.
27. KM Van Nostrand, JA Lucci, M Schell, et al. (1994) Primary vaginal melanoma: Improved survival with radical pelvic surgery. Gynecol Oncol 55 234-237.
28. WA Tjalma, JM Monaghan, A de Barros Lopes, et al. (2001) Primay vaginal melanoma and long-term survivors. Eur J Gynaecol Oncol 22 20-22.
29. S Dessureault, S-J Soong, MI Ross, et al. (2001) Imporved staging of node-negative patients with intermediate to thick melanomas (> 1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol 8 766-770.
30. C Levenback, TW Burge, DM Gershenson, et al. (1994) Intraoperative mapping for vulvar cancer. Obstet Gynecol 84 163-167.
31. JA de Hullu, H Hollema, HJ Hoekstra, et al. (2002) Vulvar melanoma: Is there a role for sentinel lymph node biopsy? Cancer 94 486-491.
32. CM Balch, S Soong, MI Ross, et al. (2000) Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7 75-76.
33. DL Morton, JF Thompson, R Essner, et al. (1999) Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 230 453-463.
34. KC Clark, WR Butz and MR Hapke (1999) Primary malignant melanoma of the uterine cervix: Case report with world literature review. Int J Gynecol Pathol 18 265-273.
35. N Vimla, L Kumar, S Thulkar, et al. (2001) Primary malignant melanoma in ovarian cystic teratoma. Gynecol Oncol 82 380-383.
36. JM Kirkwood, JG Ibrahim, JA Sosman, et al. (2001) High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IiB-III melanoma: Results of Intergroup Trial E1694/S9512/C509801. J Clin Oncol 19 2370-2380.
37. JM Kirkwood, J Ibrahim, DH Lawson, et al. (2001) High-dose inter-feron alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: Results of the multicenter eastern cooperative oncology group phase II trial E2696. J Clin Oncol 19 1430-1436.
38. MB Lens and M Dawes (2002) Interferon alfa therapy for malignant melanoma: A systemic review of randomized controlled trials. J Clin Oncol 20 1818-1825.
39. CF Verschraegen, M Benjapibal, W Supakarapongkul, et al. (2001) Vulvar melanoma at the MD Anderson Cancer Center: 25 Years later. Int J Gynecol Cancer 11 359-364.
40. WP Irvin, SA Bliss, LW Rice, et al. (1998) Malignant melanoma of the vagina and locoregional control: Radical surgery revisited. Gynecol Oncol 71 476-480.
41. E Petru, F Nagele, K Czerwenka, et al. (1998) Primary malignant melanoma of the vagina: Long-term remission following radiation therapy. Gynecol Oncol 70 23-26.